Clinical Trial Update: Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GLS-010 injection in recurrent or metastatic cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• GLS-010

Snippet

Sponsor: Guangzhou Gloria Biosciences Co., Ltd. | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN